MMP9 and cancer: While different vascular strategies may be considered in differential clinical conditions from the recovery of limb ischemia to the suppression of cancer growth, it would be interesting to investigate whether the expressions of MMP-2 and MMP-9 expressions in EPCs could be optimized for either pro-angiogenesis or anti-angiogenesis depending on the clinical indications.